NASDAQ:PCVX
Vaxcyte, Inc.
- Stock
Last Close
64.55
03/05 20:00
Market Cap
6.12B
Beta: 0.96
Volume Today
609.85K
Avg: 962.38K
PE Ratio
−25.01
PFCF: −32.24
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|
average inventory | -500K - | ||||||
average payables | 3.10M - | 16.58M 434.34% | 18.27M 10.20% | 8.28M 54.70% | 12.19M 47.30% | ||
average receivables | 500K - | ||||||
book value per share | -2.26 - | -4.16 84.27% | 11.71 381.69% | 5.47 53.27% | 14.70 168.71% | 0.01 99.91% | |
capex per share | -0.07 - | -0.05 32.64% | -0.04 16.26% | -0.13 222.95% | -0.09 28.60% | -0.00 99.82% | |
capex to depreciation | -1.71 - | -0.97 43.30% | -0.82 15.25% | -1.90 130.66% | -0.64 66.46% | -1.58 148.33% | |
capex to operating cash flow | 0.06 - | 0.03 56.47% | 0.02 2.28% | 0.05 117.99% | 0.03 36.52% | 0.05 57.88% | |
capex to revenue | |||||||
cash per share | 2.58 - | 2.30 10.76% | 13.07 467.36% | 4.74 63.76% | 14.36 203.04% | 0.01 99.92% | |
days of inventory on hand | |||||||
days payables outstanding | |||||||
days sales outstanding | |||||||
debt to assets | 0.01 - | 0.00 62.12% | 0.05 - | 0.02 65.54% | 0.02 16.41% | ||
debt to equity | -0.01 - | -0.00 80.92% | 0.06 - | 0.02 68.16% | 0.02 25.22% | ||
dividend yield | 0.00 - | ||||||
earnings yield | -0.04 - | -0.08 81.44% | -0.11 39.97% | -0.08 27.57% | -0.08 4.93% | -0.00 99.91% | |
enterprise value | 603.77M - | 610.59M 1.13% | 398.83M 34.68% | 1.18B 196.62% | 2.29B 93.93% | 6.10T 265,839.26% | |
enterprise value over ebitda | -21.25 - | -12.49 41.20% | -4.59 63.25% | -12.04 162.14% | -12.09 0.43% | -13.04K 107,731.20% | |
ev to operating cash flow | -19.82 - | -12.95 34.65% | -8.55 33.96% | -9.75 13.93% | -13.45 37.99% | -20.56K 152,763.78% | |
ev to sales | |||||||
free cash flow per share | -1.26 - | -1.89 49.94% | -1.62 14.36% | -2.46 52.37% | -2.72 10.36% | -0.00 99.88% | |
free cash flow yield | -0.05 - | -0.07 49.94% | -0.06 15.71% | -0.10 70.18% | -0.06 45.24% | -0.00 99.91% | |
graham net net | -2.44 - | -4.42 81.13% | 11.48 359.87% | 3.96 65.50% | 13.55 241.99% | 0.01 99.93% | |
graham number | 7.64 - | 13.98 82.85% | 27.98 100.15% | 15.40 44.95% | 34.95 126.92% | 0.03 99.90% | |
income quality | 1.03 - | 0.94 9.24% | 0.52 44.27% | 1.21 132.09% | 0.76 37.07% | 0.74 3.35% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -473.77 - | -1.35K 185.75% | -12.80K 845.27% | -14.81K 15.73% | -116.13K 684.12% | ||
interest debt per share | 0.02 - | 0.01 62.29% | 0.00 96.98% | 0.32 136,388.56% | 0.28 14.47% | 0.00 99.89% | |
inventory turnover | |||||||
invested capital | -0.01 - | -0.00 80.92% | 0.06 - | 0.02 68.16% | 0.02 25.22% | ||
market cap | 669.40M - | 669.40M 0% | 785.03M 17.27% | 1.24B 57.35% | 3.11B 151.85% | 6.10T 196,033.08% | |
net current asset value | -61.86M - | -110.35M 78.38% | 342.02M 409.95% | 216.03M 36.84% | 889.99M 311.98% | 928.50M 4.33% | |
net debt to ebitda | 2.31 - | 1.20 47.89% | 4.45 269.42% | 0.53 88.05% | 4.30 710.25% | 0.79 81.72% | |
net income per share | -1.15 - | -2.09 81.44% | -2.97 42.22% | -1.93 35.15% | -3.69 91.62% | -0.00 99.89% | |
operating cash flow per share | -1.19 - | -1.84 54.75% | -1.58 14.31% | -2.34 48.15% | -2.63 12.47% | -0.00 99.88% | |
payables turnover | |||||||
receivables turnover | |||||||
research and ddevelopement to revenue | |||||||
return on tangible assets | -0.42 - | -0.81 95.54% | -0.22 72.55% | -0.31 38.03% | -0.24 22.82% | -0.29 19.96% | |
revenue per share | |||||||
roe | 0.51 - | 0.50 1.53% | -0.25 150.49% | -0.35 38.77% | -0.25 28.69% | -0.32 29.04% | |
roic | 0.76 - | 0.54 28.06% | -0.25 146.92% | -0.33 28.04% | -0.25 22.90% | -0.36 43.17% | |
sales general and administrative to revenue | |||||||
shareholders equity per share | -2.26 - | -4.16 84.27% | 11.71 381.69% | 5.47 53.27% | 14.70 168.71% | 0.01 99.91% | |
stock based compensation to revenue | |||||||
tangible asset value | -57.73M - | -106.37M 84.27% | 345.84M 425.12% | 284.02M 17.88% | 953.61M 235.76% | 1.24B 30.08% | |
tangible book value per share | -2.26 - | -4.16 84.27% | 11.71 381.69% | 5.47 53.27% | 14.70 168.71% | 0.01 99.91% | |
working capital | 59.95M - | 50.67M 15.48% | 342.14M 575.22% | 227.63M 33.47% | 902.03M 296.27% | 950.62M 5.39% |
All numbers in USD (except ratios and percentages)